FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Methotrexate Sodium Injection
Status: Currently in Shortage
»Date first posted: 04/24/2017
»Therapeutic Categories: Oncology

Expand all

Accord Healthcare Inc. (Revised 10/26/2017)

Company Contact Information:
800-843-7477

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25 mg/mL; 2mL (NDC 16729-277-30) Available Available
25 mg/mL; 40 mL (NDC 16729-277-35) Available Available
25 mg/mL; 10 mL (NDC 16729-277-03) Available Available

Fresenius Kabi USA, LLC (Revised 07/26/2018)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 gram per vial, 50 mL vial, SDV (NDC 63323-122-50) Backordered. Next release anticipated August 2018. Demand increase for the drug
250 mg per 10 mL, vial (NDC 63323-123-10) Available Check wholesalers for inventory. Demand increase for the drug

Hospira, Inc. (Reverified 08/08/2018)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg/2 mL (25 mg/mL); Glass Fliptop Vial (NDC 61703-0350-38) Limited Supply Available. Next Delivery and Estimated Recovery: September 2018 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
1 g/40 mL (25 mg/mL); Single Dose Glass Fliptop Vial (NDC 61703-0408-41) Available Other

Mylan Institutional (Reverified 07/31/2018)

Company Contact Information:
800-RXMYLAN (1-800-796- 9526)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1000 mg/40 mL (NDC 67457-480-40) Available Available Demand increase for the drug

Teva Pharmaceuticals (Reverified 07/11/2018)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
25MG/ML 1X40ML (NDC 00703-3678-01) Teva has limited inventory and product is being allocated. Limited supply on allocation is projected until demand stabilizes. Demand increase for the drug
25MG/ML 1X40ML Premier label (NDC 00703-3678-81) Teva has limited inventory and product is being allocated. Limited supply on allocation is projected until demand stabilizes. Demand increase for the drug
25MG/ML 1X10ML (NDC 00703-3675-01) Teva has limited inventory and product is being allocated. Limited supply on allocation is projected until demand stabilizes. Demand increase for the drug
25MG/ML SDV 10X2ML (NDC 00703-3671-03) Teva has transitioned this product from a 10 pack to a single vial (25MG/ML SDV 1X2ML (NDC 00703-3671-01). Inventory is available in the single vial, but no inventory exist in the 10 pack. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English